Cargando…

Prediction of Gastric Cancer Development by Serum Pepsinogen Test and Helicobacter pylori Seropositivity in Eastern Asians: A Systematic Review and Meta-Analysis

BACKGROUND: To identify high-risk groups for gastric cancer in presumptively healthy populations, several studies have investigated the predictive ability of the pepsinogen test, H. Pylori antibodies, and a risk-prediction model based on these two tests. To investigate whether these tests accurately...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terasawa, Teruhiko, Nishida, Hiroshi, Kato, Katsuaki, Miyashiro, Isao, Yoshikawa, Takaki, Takaku, Reo, Hamashima, Chisato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196955/ https://www.ncbi.nlm.nih.gov/pubmed/25314140 http://dx.doi.org/10.1371/journal.pone.0109783

Ejemplares similares

Helicobacter pylori eradication treatment for gastric carcinoma prevention in asymptomatic or dyspeptic adults: systematic review and Bayesian meta-analysis of randomised controlled trials
por: Terasawa, Teruhiko, et al.
Publicado: (2019)

Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests
por: Hamashima, Chisato, et al.
Publicado: (2017)

Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection
por: Lee, Sun-Young
Publicado: (2016)

Long‐term Effect of Helicobacter pylori Infection on Serum Pepsinogens
por: Kikuchi, Shogo, et al.
Publicado: (2000)

Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection
por: Kikuchi, Shogo, et al.
Publicado: (2019)

Helicobacter pylori antibody and pepsinogen testing for predicting gastric microbiome abundance
por: Choi, Saemi, et al.
Publicado: (2019)

Serum Pepsinogen Values in Japanese Junior High School Students With Reference to Helicobacter Pylori Infection
por: Okuda, Masumi, et al.
Publicado: (2020)

Effectiveness of decision aids on cancer-screening decision-making: an umbrella review protocol
por: Hibino, Masaya, et al.
Publicado: (2021)

Radiographic and endoscopic screening to reduce gastric cancer mortality: a systematic review and meta-analysis
por: Hibino, Masaya, et al.
Publicado: (2023)

Effect of Smoking on Serum Pepsinogen I Level Depends on Serological Status of Helicobacter pylori
por: Tatemichi, Masayuki, et al.
Publicado: (2001)

Helicobacter pylori Seropositivity and Risk of Lung Cancer
por: Koshiol, Jill, et al.
Publicado: (2012)

Association of serum pepsinogens and gastrin-17 with Helicobacter pylori infection assessed by urea breath test
por: Zhou, Jun-peng, et al.
Publicado: (2022)

Seropositivity for Helicobacter pylori and hepatobiliary cancers in the PLCO study
por: Makkar, Rishi, et al.
Publicado: (2020)

Cognitive function in UK adults seropositive for Helicobacter pylori
por: Erickson, Lance D., et al.
Publicado: (2023)

Comparative accuracy of cervical cancer screening strategies in healthy asymptomatic women: a systematic review and network meta-analysis
por: Terasawa, Teruhiko, et al.
Publicado: (2022)

Helicobacter Pylori Infection and Serum Pepsinogen I Concentration in Peptic Ulcer Patients: Effect of Bacterial Eradication
por: Park, Sill Moo, et al.
Publicado: (1996)

Helicobacter pylori Infection, Serum Pepsinogen Level and Gastric Cancer: A Case‐Control Study in Japan
por: Fukuda, Haruhiko, et al.
Publicado: (1995)

Association between Helicobacter pylori seropositivity and mild to moderate COPD: clinical implications in an Asian country with a high prevalence of H. pylori
por: Lee, Ha Youn, et al.
Publicado: (2016)

Helicobacter pylori Seropositivity and Stool Antigen in Patients With Hyperemesis Gravidarum
por: Sinan Karadeniz, R., et al.
Publicado: (2006)

Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort
por: Abnet, C C, et al.
Publicado: (2011)

Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels
por: Eybpoosh, Sana, et al.
Publicado: (2015)

Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study
por: Leja, Marcis, et al.
Publicado: (2017)

Sero-prevalence of Helicobacter pylori CagA immunoglobulin G antibody, serum pepsinogens and haemoglobin levels in adults
por: Muhsen, Khitam, et al.
Publicado: (2018)

Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer
por: De Re, Valli, et al.
Publicado: (2016)

A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication
por: Osumi, Hiroki, et al.
Publicado: (2017)

Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects
por: Yu, Hong, et al.
Publicado: (2021)

Frequency of unsatisfactory cervical cytology smears in cancer screening of Japanese women: A systematic review and meta‐analysis
por: Hosono, Satoyo, et al.
Publicado: (2018)

National Data Analysis and Systematic Review for Human Resources for Cervical Cancer Screening in Japan
por: Hamashima, Chisato, et al.
Publicado: (2021)

The negative association between inflammatory bowel disease and Helicobacter pylori seropositivity
por: Sayar, Rasoul, et al.
Publicado: (2019)

Seropositivity of antibodies against Helicobacter pylori and hepatitis A Virus in Iran
por: Nassrolahei, Mohtaram, et al.
Publicado: (2004)

The Association between Helicobacter pylori Seropositivity and Bone Mineral Density in Adults
por: Huang, Jinke, et al.
Publicado: (2022)

Helicobacter pylori healthy South Asians
por: Kharel, Sanjeev, et al.
Publicado: (2020)

Helicobacter pylori infection, serum pepsinogens as markers of atrophic gastritis, and leukocyte telomere length: a population-based study
por: Muhsen, Khitam, et al.
Publicado: (2019)

Brand interchangeability of pepsinogen tests in the real-world setting after eradication of Helicobacter pylori: a community-based study
por: Chiang, Tsung-Hsien, et al.
Publicado: (2022)

Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening
por: Chen, Xian-Zhe, et al.
Publicado: (2018)

Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens
por: Shimoyama, Tadashi, et al.
Publicado: (2017)

Prediction of true Helicobacter pylori-uninfected status using a combination of age, serum antibody and pepsinogen: Logistic regression analysis
por: Takayama, Takako, et al.
Publicado: (2020)

Serum Pepsinogen Values and Helicobacter pylori Status among Control Subjects of a Nested Case-Control Study in the JACC study
por: Kikuchi, Shogo, et al.
Publicado: (2005)

Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method”
por: MIKI, Kazumasa
Publicado: (2011)

Role of Serum Pepsinogen II and Helicobacter pylori Status in the Detection of Diffuse-Type Early Gastric Cancer in Young Individuals in South Korea
por: Baek, Sung Min, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t45vufsb9tqd82t6c3rgdf1ck1